Suppr超能文献

抗生素生产与抗生素抗性:AbrB1/B2双组分系统的两面

Antibiotic Production and Antibiotic Resistance: The Two Sides of AbrB1/B2, a Two-Component System of .

作者信息

Sánchez de la Nieta Ricardo, Antoraz Sergio, Alzate Juan F, Santamaría Ramón I, Díaz Margarita

机构信息

Instituto de Biología Funcional y Genómica/Departamento de Microbiología y Genética, Consejo Superior de Investigaciones Científicas/Universidad de Salamanca, Salamanca, Spain.

Departamento de Microbiología y Parasitología, Facultad de Medicina, Centro Nacional de Secuenciación Genómica, Sede de Investigación Universitaria, Universidad de Antioquia, Medellín, Colombia.

出版信息

Front Microbiol. 2020 Oct 9;11:587750. doi: 10.3389/fmicb.2020.587750. eCollection 2020.

Abstract

Antibiotic resistance currently presents one of the biggest threats to humans. The development and implementation of strategies against the spread of superbugs is a priority for public health. In addition to raising social awareness, approaches such as the discovery of new antibiotic molecules and the elucidation of resistance mechanisms are common measures. Accordingly, the two-component system (TCS) of AbrB1/B2, offer amenable ways to study both antibiotic production and resistance. Global transcriptomic comparisons between the wild-type strain M145 and the mutant Δ, using RNA-Seq, showed that the AbrB1/B2 TCS is implicated in the regulation of different biological processes associated with stress responses, primary and secondary metabolism, and development and differentiation. The Δ mutant showed the up-regulation of antibiotic biosynthetic gene clusters and the down-regulation of the vancomycin resistance gene cluster, according to the phenotypic observations of increased antibiotic production of actinorhodin and undecylprodigiosin, and greater susceptibility to vancomycin. The role of AbrB1/B2 in vancomycin resistance has also been shown by an analysis, which strongly indicates that AbrB1/B2 is a homolog of VraR/S from and LiaR/S from /, both of which are implied in vancomycin resistance in these pathogenic organisms that present a serious threat to public health. The results obtained are interesting from a biotechnological perspective since, on one hand, this TCS is a negative regulator of antibiotic production and its high degree of conservation throughout spp. makes it a valuable tool for improving antibiotic production and the discovery of cryptic metabolites with antibiotic action. On the other hand, AbrB1/B2 contributes to vancomycin resistance and is a homolog of VraR/S and LiaR/S, important regulators in clinically relevant antibiotic-resistant bacteria. Therefore, the study of AbrB1/B2 could provide new insight into the mechanism of this type of resistance.

摘要

抗生素耐药性目前是对人类最大的威胁之一。制定和实施应对超级细菌传播的策略是公共卫生的首要任务。除了提高社会意识外,发现新的抗生素分子和阐明耐药机制等方法也是常见措施。因此,AbrB1/B2的双组分系统(TCS)为研究抗生素生产和耐药性提供了合适的途径。使用RNA-Seq对野生型菌株M145和突变体Δ进行的全转录组比较表明,AbrB1/B2 TCS参与调控与应激反应、初级和次级代谢以及发育和分化相关的不同生物学过程。根据放线紫红素和十一烷基灵菌红素抗生素产量增加以及对万古霉素敏感性增强的表型观察,Δ突变体显示抗生素生物合成基因簇上调,而万古霉素耐药基因簇下调。对AbrB1/B2在万古霉素耐药性中的作用分析也表明,AbrB1/B2是来自[具体物种1]的VraR/S和来自[具体物种2]的LiaR/S的同源物,这两者在对公共卫生构成严重威胁的这些致病生物的万古霉素耐药性中都有涉及。从生物技术角度来看,所获得的结果很有趣,一方面,这个TCS是抗生素生产的负调控因子,并且在整个[具体菌属]中具有高度保守性,使其成为提高抗生素产量和发现具有抗生素作用的隐秘代谢物的有价值工具。另一方面,AbrB1/B2有助于万古霉素耐药性,并且是VraR/S和LiaR/S的同源物,而VraR/S和LiaR/S是临床相关抗生素耐药细菌中的重要调控因子。因此,对AbrB1/B2的研究可以为这种耐药性的机制提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfda/7581861/2eb8b9597188/fmicb-11-587750-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验